The FDA issues safety alerts for EpiPen and EpiPen Jr Auto-Injectors; we should be drinking more water to reduce the effects of increased sugar intake; experts suggest actively working to protect mental health while on lockdown.
A safety alert went out last evening from the FDA about EpiPen 0.3-mg and EpiPen Jr 0.15-mg Auto-Injectors following a letter that manufacturer Mylan sent to healthcare providers. In the letter, Mylan warned about possible device malfunction on the part of the safety release, spontaneous device activation, and device removal from the carrier tube. All parties concerned should continue to periodically review the EpiPen instructions and inspect their devices before use. Pharmacists should also inspect the pens prior to dispensing them. As always, the FDA encourages everyone to report adverse events to its MedWatch Safety Information and Adverse Event Reporting Program.
Working remotely and being on lockdown may mean a change to our regular workday eating habits, namely in the form of more sugar, according to Forbes. Researchers believe we should increase our water intake as a result, to help lessen the effects from excess buildup of uric acid, which accumulates in our blood from the breakdown of purines. The uric acid itself results from excess sugar intake. Higher sugar levels in our blood can also signal such metabolic disorders as diabetes and heart disease/inflammation.
The National Alliance on Mental Health has suggested that we must actively work to combat any mental distress brought on by the coronavirus disease 2019 (COVID-19) pandemic, according to the organization’s website. With top worries that include anxiety, loneliness, and stress centered on getting sick, losing money, and risking exposure to the virus, experts offer several coping strategies. These include being more conscious of where we get our news from, taking time for self-care, helping others, and having activities lined up to distract ourselves.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More